rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
5
|
pubmed:dateCreated |
2005-4-21
|
pubmed:abstractText |
Large interferon-based therapeutic trials are still lacking in children with hepatitis C and the long-term safety and efficacy of interferon is unknown. This study describes the outcome of hepatitis C in 43 children enrolled in an open-label interferon trial, and were followed up to 66 months after stopping treatment.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
1590-8658
|
pubmed:author |
pubmed-author:BalliFF,
pubmed-author:BarberaCC,
pubmed-author:BartolacciSS,
pubmed-author:BortolottiFF,
pubmed-author:GiacchinoRR,
pubmed-author:GuidoMM,
pubmed-author:GussettiNN,
pubmed-author:IorioRR,
pubmed-author:MaccabruniAA,
pubmed-author:MarcelliniMM,
pubmed-author:NebbiaGG,
pubmed-author:VegnenteAA,
pubmed-author:VerucchiGG,
pubmed-author:ZancanLL
|
pubmed:issnType |
Print
|
pubmed:volume |
37
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
336-41
|
pubmed:dateRevised |
2011-11-17
|
pubmed:meshHeading |
pubmed-meshheading:15843083-Adolescent,
pubmed-meshheading:15843083-Antiviral Agents,
pubmed-meshheading:15843083-Disease Progression,
pubmed-meshheading:15843083-Female,
pubmed-meshheading:15843083-Hepacivirus,
pubmed-meshheading:15843083-Hepatitis C, Chronic,
pubmed-meshheading:15843083-Humans,
pubmed-meshheading:15843083-Interferon-alpha,
pubmed-meshheading:15843083-Male,
pubmed-meshheading:15843083-RNA, Viral,
pubmed-meshheading:15843083-Recombinant Proteins,
pubmed-meshheading:15843083-Remission Induction
|
pubmed:year |
2005
|
pubmed:articleTitle |
Interferon treatment in children with chronic hepatitis C: long-lasting remission in responders, and risk for disease progression in non-responders.
|
pubmed:affiliation |
Clinica Medica 5, University, Padua, Italy. flavia.bortolotti@unipd.it
|
pubmed:publicationType |
Journal Article
|